News

Banned By Columbia, Backed By Millions: 21-Year-Old's AI Startup Cluely Lets You Cheat On Exams, Interviews, And Sales Calls
Cluely, a provocative AI startup born from academic controversy, just closed a $5.3 million seed round led by Abstract ...
New Long-Term Follow-Up Data from OPTIMA II Study of UGN-102 Demonstrates Median Duration of Response of Two Years in Patients with LG-IR-NMIBC
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced new data from the ...